Efficacy of a Mediterranean diet in primary prevention of heart failure and atrial fibrillation in high risk hypertensive patients

Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)0 个研究点目标入组 180 人开始时间: 2012年7月12日最近更新: 2020年8月24日

适应症

试验速览

暂无简介。

•Participants are community-dwelling hypertensive patients, 55 to 75 years old, at high cardiovascular risk, with pharmacological treatment antihypertensive, without a personal documented history of cardiovascular disease (CVD): coronary heart disease, stroke, heart failure (HF) or atrial fibrillation (AF), who fulfill at least one of the two following criteria:
•1. Type 2 diabetes mellitus
•2. Two or more of the cardiovascular risk factors:
•2.1. Current smoker
•2.2. Lipid disorders (low density lipoprotein cholesterol [LDL-cholesterol] = 160 mg/dl or high density lipoprotein cholesterol [HDL -cholesterol] < 40 mg/dl or treatment with hypolipidemic drugs)
•2.3. Obesity (body mass index = 30 Kg/m2)
•2.4. Family history of premature CVD

•1. Previous history of cardiovascular disease (coronary heart disease, stroke, HF or AF)
•2. Body mass index > 40 Kg/m2
•3. Severe chronic disease with poor prognosis
•4. Illegal drug use or chronic alcoholism
•5. Physical limitations, mental or intellectual berriers to participate in the trial
•6. Low predicted likelihood of changing dietary habits
•7. Any condition that may affect the development of the trial

发起方

Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)